Neurocrine Biosciences schedules Q3 2026 results conference call and webcast

• Neurocrine Biosciences scheduled its Q3 2026 results release for Nov. 2, 2026.
• Conference call and webcast set for Nov. 2, 2026 at 1:30 p.m. PT.
• Webcast access via https://www.neurocrine.com.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurocrine Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610121601PR_NEWS_USPR_____LA70175) on October 12, 2026, and is solely responsible for the information contained therein.